184 related articles for article (PubMed ID: 18798556)
1. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolism in children with sarcoma.
Athale U; Cox S; Siciliano S; Chan AK
Pediatr Blood Cancer; 2007 Aug; 49(2):171-6. PubMed ID: 16991135
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolism in children with lymphoma.
Athale UH; Nagel K; Khan AA; Chan AK
Thromb Res; 2008; 122(4):459-65. PubMed ID: 18237767
[TBL] [Abstract][Full Text] [Related]
4. Central venous line dysfunction is an independent predictor of poor survival in children with cancer.
Athale UH; Siciliano S; Cheng J; Thabane L; Chan AK
J Pediatr Hematol Oncol; 2012 Apr; 34(3):188-93. PubMed ID: 22278202
[TBL] [Abstract][Full Text] [Related]
5. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolic complications in pediatric hematologic malignancies.
Athale UH; Chan AK
Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
Hanson SJ; Punzalan RC; Greenup RA; Liu H; Sato TT; Havens PL
J Trauma; 2010 Jan; 68(1):52-6. PubMed ID: 20065757
[TBL] [Abstract][Full Text] [Related]
9. Thromboembolism in hospitalized neutropenic cancer patients.
Khorana AA; Francis CW; Culakova E; Fisher RI; Kuderer NM; Lyman GH
J Clin Oncol; 2006 Jan; 24(3):484-90. PubMed ID: 16421425
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
11. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
12. Significant association with location of central venous line placement and risk of venous thrombosis in children.
Male C; Julian JA; Massicotte P; Gent M; Mitchell L;
Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
[TBL] [Abstract][Full Text] [Related]
13. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.
Ziegler S; Sperr WR; Knöbl P; Lehr S; Weltermann A; Jäger U; Valent P; Lechner K
Thromb Res; 2005; 115(1-2):59-64. PubMed ID: 15567454
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
16. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
Bugert P; Pabinger I; Stamer K; Vormittag R; Skeate RC; Wahi MM; Panzer S
Thromb Haemost; 2007 Apr; 97(4):573-80. PubMed ID: 17393020
[TBL] [Abstract][Full Text] [Related]
17. Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?
Halton J; Nagel K; Brandão LR; Silva M; Gibson P; Chan A; Blyth K; Hicks K; Parmar N; Paddock L; Willing S; Thabane L; Athale U
BMC Cancer; 2012 Jul; 12():314. PubMed ID: 22835078
[TBL] [Abstract][Full Text] [Related]
18. Hypophosphatemia in critically ill children: prevalence and associated risk factors.
Santana e Meneses JF; Leite HP; de Carvalho WB; Lopes E
Pediatr Crit Care Med; 2009 Mar; 10(2):234-8. PubMed ID: 19057439
[TBL] [Abstract][Full Text] [Related]
19. Arterial thromboembolic disease: a single-centre case series study.
Monagle P; Newall F; Barnes C; Savoia H; Campbell J; Wallace T; Crock C
J Paediatr Child Health; 2008 Jan; 44(1-2):28-32. PubMed ID: 17803664
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
